Eksempler på brug af Infanrix penta på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
What is Infanrix Penta?
Infanrix Penta should not be given.
How does Infanrix Penta work?
Other information about Infanrix Penta.
How is Infanrix Penta used?
Before your child receives Infanrix Penta 3.
What is Infanrix Penta used for?
Take special care with Infanrix Penta.
What benefit has Infanrix Penta shown during the studies?
Infanrix Penta is a vaccine, which is available as a suspension for injection.
Suspension for injection Infanrix Penta is a turbid white suspension.
Infanrix Penta is available in packs of 1, 10, 20 and 50 with or without needles.
The active substances andother ingredients in Infanrix Penta are listed at the end of the leaflet.
Infanrix Penta has been studied in 16 studies looking at the first course of vaccination.
As with other vaccines, administration of Infanrix Penta should be postponed in subjects suffering from acute severe febrile illness.
Infanrix Penta is a white, slightly milky liquid presented in a pre-filled syringe 0.5 ml.
The studies showed that a first course of vaccination with Infanrix Penta led to the development of protective levels of antibodies.
Infanrix Penta can be considered for the booster if the composition is in accordance with the official recommendations.
Percentage of subjects with antibody titres≥ assay cut-off one month after booster vaccination with Infanrix Penta Antibody cut-off.
In virtually all instances, Infanrix Penta was administered at the same time as a Hib vaccine.
Protective antibodies against hepatitis B have been shown to persist for at least 3.5 years in more than 90% of children administered four doses of a combined vaccine containing the same HBs antigen as 7 Infanrix Penta.
Clinical studies have demonstrated that Infanrix Penta can be administered simultaneously with Haemophilus influenzae type b vaccines.
Infanrix Penta is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B and poliomyelitis.
If your child has previously had any allergic reaction to Infanrix Penta, or any ingredient contained in this vaccine.
A booster dose of Infanrix Penta or a similar vaccine must be given at least six months after the last dose of the initial course.
The studies involved over 10,000 infants, about three quarters of whom received Infanrix Penta, given according to various time schedules.
Infanrix Penta is used to vaccinate infants under three years of age against diphtheria, tetanus, pertussis(whooping cough), hepatitis B and poliomyelitis polio.
The European Commission granted a marketing authorisation valid throughout the EU for Infanrix Penta to GlaxoSmithKline Biologicals s. a. on 23 October 2000.
Infanrix Penta has also been studied in nine studies of booster vaccination involving over 4,000 infants, 714 of whom received Infanrix Penta as a booster.
As the immune response to pertussis antigens following Infanrix Penta administration is equivalent to that of Infanrix, the protective efficacy of the two vaccines is expected to be equivalent.